Within the long and restless contest between the body and the diseases that arise from within it, researchers at UT Southwestern have described a quiet strategy that tumors appear to use: they push acid outward until it hardens into a boundary the immune system struggles to cross. The finding, led by Jinming Gao and reported in Nature Biomedical Engineering, belongs to an old and familiar truth that cancer's acidity is no accident of its metabolism but can be shaped into a defense. It opens a modest but meaningful door, suggesting that the very barrier a tumor builds to protect itself might on
Scientists Map How Tumors Build an 'Acid Wall' to Shield Themselves From Immune Attack
A wall of heightened acidity along the tumor's outer boundary
So what did the team actually find?
That tumor cells are acidic on one side only, and they push that acid outward, so a wall of acidity forms around the tumor's edge.
And why does that matter for the immune system?
In human tumor samples, that acidic zone was largely empty of killer T cells. The cells the body counts on to attack cancer weren't getting through.
Careful, though. The samples show absence of T cells where the acid is. The reporting presents the wall as protective, but I'd want to know how directly the study shows the acid is the cause.
Fair. The source says the team concluded the cancer created the wall to protect itself, but it doesn't spell out the experiments behind that step.
What about the probes?
Nanoscale probes measured pH across individual cells, which is how they saw the one-sided acidity.
And how many tumors or samples? The article doesn't say. That's unknown.
What could come of it?
Drugs that release their payload in acidic conditions, so they act only at the tumor, or drugs that block the wall so T cells can reach it.
Both are possibilities. Nothing here says a drug exists yet.
Le Pouls
- Tumor cells are pumping acid outward, forming a dense acidic wall that keeps killer T cells from reaching the cancer.
- Human tumor samples revealed the wall nearly empty of the immune cells the body depends on to fight disease.
- Researchers are weighing whether drugs could target this acidic boundary to release treatment only at the tumor's edge.
- A second route is taking shape: blocking acid production so the tumor's shield collapses and immune attack can resume, though both paths remain early prospects.
Within the long and restless contest between the body and the diseases that arise from within it, researchers at UT Southwestern have described a quiet strategy that tumors appear to use: they push acid outward until it hardens into a boundary the immune system struggles to cross. The finding, led by Jinming Gao and reported in Nature Biomedical Engineering, belongs to an old and familiar truth that cancer's acidity is no accident of its metabolism but can be shaped into a defense. It opens a modest but meaningful door, suggesting that the very barrier a tumor builds to protect itself might one day help physicians aim treatment more precisely or dismantle the shield entirely.
At the University of Texas Southwestern, researchers have uncovered a way tumors may hold the immune system at a distance. Cancer cells, it appears, pump acid outward until it forms a barrier around their edges, and that barrier keeps the body's defenders away. The work, led by Jinming Gao and published in Nature Biomedical Engineering, examines one of three broad ways cancer resists the body, the physical shield, which had received less attention than hiding from or fighting the immune system.
Scientists have long known that tumors are more acidic than healthy tissue, largely because their metabolism produces lactic acid. What was unclear was how that acidity is arranged. Using nanoscale probes, Gao's team found that individual cancer cells were markedly more acidic on one side than the other. Across whole tumors, that pattern grew into a ring of heightened acidity along the outer boundary, with acid being pushed away from neighboring cancer cells and into the surrounding tissue.
When the team examined human tumor samples, that acidic wall was largely free of killer T cells. The researchers concluded the tumor uses the wall to shield itself from attack, a polarized acidity Gao describes as prevalent around cancer cells.
The discovery points toward two possible uses. The acidic boundary might signal where a drug should release its active ingredients, delivering treatment precisely to the tumor. Alternatively, a better understanding of the process could lead to drugs that prevent the wall from forming, leaving the cancer exposed. Both remain prospects rather than therapies, but the study offers a clearer map of the ground on which the next steps will be taken.
Researchers at the University of Texas Southwestern have described a way tumors may keep the immune system at arm's length: by pumping acid outward until it forms a barrier around their own edges. The work, led by Jinming Gao and published in the journal Nature Biomedical Engineering, focuses on one of three broad strategies cancer cells use against the body's defenses.
As the study frames it, cancer cells can hide from the immune system, fight back against it, or put up a physical barrier. The UT Southwestern team set out to investigate that third approach.
The starting point is something scientists have known for a long time. Tumors are somewhat more acidic than healthy tissue, largely because their metabolism produces lactic acid as a waste byproduct. What had not been clear was how that acidity is distributed, and it turns out not to be uniform across cancer cells.
Gao and his colleagues used nanoscale probes to measure pH across individual tumor cells. They found that the cells were significantly more acidic on one side than on the other. In the researchers' terms, the acidity was polarized.
When the team ran similar tests on whole tumor tissue, a larger pattern emerged. The cancer cells were pushing acid away from neighboring cancer cells and out into the surrounding environment. The result was a wall of heightened acidity along the tumor's outer boundary.
The researchers then examined samples of human tumor tissue. The acidic wall in those samples was largely devoid of killer T cells, the immune cells the body relies on to fight infection and other harmful cell types. From this, the team concluded that the tumor was using the acid wall to protect itself from immune attack. In a statement, Gao said the study revealed a previously unrecognized polarized extracellular acidity that is prevalent around cancer cells.
The findings carry two possible implications for drug development. First, the acidity around a tumor could serve as a signal for targeted treatments, so that a drug releases its active ingredients only at the tumor site. Second, as understanding of the process improves, it may become possible to design drugs that stop cancer cells from building the acid wall in the first place, leaving them more exposed to the immune system.
Both ideas remain prospects rather than treatments. The work describes the mechanism and points toward the next step: whether drugs can be built to use the acid wall as a target or to take it down.
Citations marquantes
The study revealed a previously unrecognized polarized extracellular acidity that is prevalent around cancer cells.— Jinming Gao, UT Southwestern